ClinVar Miner

Submissions for variant NM_003718.5(CDK13):c.2524A>G (p.Asn842Asp)

dbSNP: rs1554333853
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Undiagnosed Diseases Network, NIH RCV000625958 SCV000746556 likely pathogenic Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 2016-12-08 criteria provided, single submitter clinical testing This variant has been reported in PMID:28807008 (individual 1001).
Department of Medical Genetics, Oslo University Hospital RCV000625958 SCV001437574 likely pathogenic Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 2016-05-18 criteria provided, single submitter clinical testing
Invitae RCV001383184 SCV001582256 pathogenic not provided 2020-04-01 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Asn842 amino acid residue in CDK13. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 27479907, 28554332, 28807008). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). This variant has been observed in individual(s) with CDK13-related disease (PMID: 28807008, 29021403). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 522794). This variant is not present in population databases (ExAC no frequency). This sequence change replaces asparagine with aspartic acid at codon 842 of the CDK13 protein (p.Asn842Asp). The asparagine residue is highly conserved and there is a small physicochemical difference between asparagine and aspartic acid.
Daryl Scott Lab, Baylor College of Medicine RCV000625958 SCV002072584 pathogenic Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 2022-01-27 criteria provided, single submitter clinical testing
OMIM RCV000625958 SCV000680088 pathogenic Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 2024-02-15 no assertion criteria provided literature only
GeneReviews RCV000625958 SCV001370886 not provided Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder no assertion provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.